MIN-TSUN LIAOTING TSE LINCHUN-KAI CHENCheng, L.-Y.L.-Y.ChengTing, H.-W.H.-W.TingYEN BIN LIU2021-02-022021-02-022020https://www.mdpi.com/2077-0383/9/11/3677https://scholars.lib.ntu.edu.tw/handle/123456789/545948[SDGs]SDG3angiotensin receptor antagonist; antiarrhythmic agent; beta adrenergic receptor blocking agent; C reactive protein; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; high sensitivity C reactive protein; unclassified drug; aged; Article; atrial fibrillation; atrial high rate episode; confidence interval; controlled study; female; follow up; hazard ratio; heart ejection fraction; heart left ventricle; heart rate; human; major clinical study; male; proportional hazards model; prospective studyHigh-Sensitivity C-Reactive Protein is a Predictor of Subsequent Atrial High-Rate Episodes in Patients with Pacemakers and Preserved Ejection Fractionjournal article10.3390/jcm9113677